Compulsory enforcement of bioequivalance test eyed

The Korea Food and Drug Administration (KFDA) says that it will positively contemplate the mandatory bioequivalance test and drug re-evaluation project on any new licensed items containing ingredients which will be subject to bioequivalence test and to this end, it will draft the relevant regulations during this May after consultation with representatives fromthe domestic pharmaceutical industr...